Dutch startup Novenda Applied sciences has secured $6.1 million in Sequence A funding to advance its multi-material 3D printing platform for dental merchandise. The funding spherical was led by Brightlands Enterprise Companions, with participation from KBC Focus Fund, Borski Fund, and the Limburg Enterprise Improvement Fund/LIOF, together with a number of enterprise angels. The corporate additionally acquired innovation funding from the Dutch funding company RVO.
The startup’s platform permits automated 3D printing of dental merchandise that mix exhausting and mushy supplies in a single printing course of. The expertise produces dental splints and prostheses with water-soluble assist buildings, eliminating the necessity for time-consuming post-processing. The system’s software program can generate a number of coloration combos utilizing fundamental colours, addressing a earlier limitation in dental 3D printing.
Based in 2019 by Klaas Wiertzema, Petra Doelman, and Joost Anne Veerman, Novenda put in its first working prototype on the Excessive Tech Campus Eindhoven in 2021. The corporate achieved a profitable proof of idea in 2023. “Our expertise combines most precision with actual ease of use. In view of the rising scarcity of expert staff in dental expertise, it is a actual sport changer,” mentioned Klaas Wiertzema, CEO of Novenda.
The corporate’s LD100 printer operates solely with proprietary supplies to make sure biocompatibility and high quality requirements. The platform can produce as much as 15 dental splints or 8 prostheses per hour, concentrating on giant and medium-sized dental laboratories in Europe and the US. Novenda at present employs 15 specialists in physics, chemistry, supplies science, and software program improvement because it prepares for worldwide growth.
Supply: startbase.com
